News

Actoverco Pharmaceutical Company

Selected News

4R4A0525

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

6 May 2025
روز کارگر-EN-08

Labor Day Tribute from Actoverco

1 May 2025
عید فطر - تلگرام - انگلیسی -04

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

1 April 2025
4R4A68781-2048x1365

First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment

9 March 2025
4R4A061511-2048x1365

Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis

27 January 2025

We do not talk, we act

10 October 2018 | Author: Actoverco

Shini, CEO of Actoverco on the sidelines of ICCU 2018 in a conversation with PHANA: With proper planning, none of the Actoverco’s drugs will not experience a shortage. We have…

nahaleh naraghi ceo of actoverco

With the lifting of sanctions, many announced their readiness to work with “Actoverco

19 January 2016 | Author: Actoverco

We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.